EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹21 Cr | ₹18 Cr | ₹19 Cr | ₹11 Cr | ₹12 Cr |
What is the latest Total Non-Current Liabilities ratio of EVEREST ORGANICS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹21 Cr |
Mar2023 | ₹18 Cr |
Mar2022 | ₹19 Cr |
Mar2021 | ₹11 Cr |
Mar2020 | ₹12 Cr |
How is Total Non-Current Liabilities of EVEREST ORGANICS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹21 Cr | 15.12 | |
Mar2023 | ₹18 Cr | -3.16 | |
Mar2022 | ₹19 Cr | 62.92 | |
Mar2021 | ₹11 Cr | -5.31 | |
Mar2020 | ₹12 Cr | - |
Compare Total Non-Current Liabilities of peers of EVEREST ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EVEREST ORGANICS | ₹391.7 Cr | 21.5% | 20.9% | 182.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,195.0 Cr | -0.3% | -3.4% | -6.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,417.0 Cr | -1.6% | -10.2% | 30.3% | Stock Analytics | |
CIPLA | ₹124,867.0 Cr | -1% | 4.8% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,971.0 Cr | 1.2% | 3.9% | 9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,956.0 Cr | -0.6% | -1.1% | -9.9% | Stock Analytics |
EVEREST ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EVEREST ORGANICS | 21.5% |
20.9% |
182.2% |
SENSEX | 2% |
0.1% |
1.8% |
You may also like the below Video Courses